To the Editor As reproductive psychiatrists, we face the challenging task of translating articles such as the one by Brown et al1 to our patients. The media have not made our task easy, with sensational headlines such as, “Maternal SSRI Use Linked to Speech, Language Disorders”2 and “Study Links Antidepressants in Pregnancy With Language Disorders.”3 Despite inherent study design difficulties4 and small absolute differences, the authors claimed that “we have provided novel evidence of an association between speech/language disorders in offspring and [serotonin reuptake inhibitor] use during pregnancy.”1
Rasminsky S, Burt VK. Serotonin Reuptake Inhibitor Use During Pregnancy. JAMA Psychiatry. 2017;74(5):538–539. doi:10.1001/jamapsychiatry.2016.4068
Psychiatry in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.